12.12.2019
- The race among international pharmaceutical producers to beef up their oncology portfolio is heating up. In one of the latest deals, US Merck has signed a definitive agreement to...
10.12.2019
- French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash...
Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan...
06.12.2019
- In various high-tech industries start-ups occupy an important place in the innovation ecosystem. Various statistics show that this holds increasingly true for the chemical sector...
02.12.2019
- Clariant has formed a strategic partnership with Plant Advanced Technologies (PAT), which will see the Swiss group take a stake of around 10% in the French plant biotech company...
Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion...
20.11.2019
- Martin Shkreli, former CEO of the Retrophin hedge fund and Turing Pharmaceuticals, who was convicted of securities fraud and conspiracy in 2017, appears to have run out of options...
20.11.2019
- The US Federal Trade Commission has approved Bristol-Myers Squibb’s $74 billion takeover of biotech Celgene by a vote of 3 to 2. The biggest merger in the history of the global...
13.11.2019
- Marc Funk resigned as CEO of Lonza on Nov. 12, citing personal reasons, after only eight months at the helm of the Swiss CDMO. The news took most observers and investors by...
04.11.2019
- US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...
